M. Vujic

Oncogenic KIT mutations in different exons lead to specific changes in melanocyte phospho-proteome.

A. Burlingame, J. Rodríguez-Peralto, J. Ma, 2016, Journal of proteomics.

Psoriasis is associated with fissured tongue but not geographic tongue: a prospective, cross‐sectional, case‐control study

D. Kivaranovic, I. Vujic, K. Rappersberger, 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

A. Burlingame, M. Dimon, A. Daud, 2018, Scientific Reports.

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells

R. Esteve-Puig, C. Posch, M. Sanlorenzo, 2016, Oncotarget.

The long non-coding RNA ‘TRASH’ is essential for cell survival in MAPK-driven melanoma

A. Daud, Y. Kohwi, T. Kohwi-Shigematsu, 2022 .

The burden of malignant melanoma--lessons to be learned from Austria.

D. Kivaranovic, W. Oberaigner, M. Hackl, 2016, European journal of cancer.

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells

R. Esteve-Puig, C. Posch, M. Sanlorenzo, 2016, Oncotarget.

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.

R. Esteve-Puig, C. Posch, M. Sanlorenzo, 2016, Oncotarget.

The lincRNA MIRAT binds to IQGAP1 and modulates the MAPK pathway in NRAS mutant melanoma

A. Burlingame, M. Dimon, A. Daud, 2018, Scientific Reports.

Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells

R. Esteve-Puig, C. Posch, I. Vujic, 2016, OncoTarget.

Cutaneous CD56+ T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma

L. Pincus, S. Ortiz-Urda, Yixuan Zheng, 2018, JAAD case reports.

The therapeutically actionable long non-coding RNA ‘T-RECS’ is essential to cancer cells’ survival in NRAS/MAPK-driven melanoma

Y. Kohwi, T. Kohwi-Shigematsu, C. Posch, 2024, Molecular cancer.